93 Results (Page 2 of 4)
Netherlands Markets Research Reports
Netherlands Over The Counter (OTC) Pharmaceuticals Market Analysis
Netherlands's over-the-counter (OTC) pharmaceuticals market size was valued at $357.5 Mn in 2022 and is estimated to expand at a CAGR of 6.54% from 2022-30 and will reach $593.4 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
Netherlands Cardiovascular Drugs Market Analysis
Netherlands Cardiovascular Drug Market is at around $0.4 Bn in 2022 and is projected to reach $0.5 Bn in 2030, exhibiting a CAGR of 4.3% during the forecast period. Increased elderly population, healthcare accessibility, and healthcare spending & affordability in the country are driving the growth of the market. The market is dominated by key players like Pfizer Inc., Novartis, Sanofi, Merck & Co., Astra Zeneca, Daiichi Sankyo, Takeda Pharmaceutical, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, and Bayer AG.
Netherlands ECG Equipments Market Analysis
Netherlands's ECG Equipment Market is expected to witness growth from $23 Mn in 2022 to $42 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-30. In the Netherlands, there is an increasing focus on preventative healthcare, which is anticipated to increase demand for ECG equipment as consumers take a more proactive approach to monitoring their cardiac health. The market is segmented by product type and by end user. Some key players in this market include Hy2Care B.V., InnoSer, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Netherlands Radiotherapy Market Analysis
By 2030, it is anticipated that the Netherlands Radiotherapy Market will reach a value of $xx Mn from $18 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in the Netherlands is dominated by a few domestic players such as Research Laboratories BV, Philips Healthcare, and Elekta BV. The radiotherapy market in the Netherlands is segmented into different types, technologies, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Netherlands Radiotherapy is increasing due to the rise in cancer cases in the country.
Netherlands Patient Engagement Solutions Market Analysis
Netherlands's patient engagement solutions market is projected to grow from $44.23 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be a collaborative healthcare system, high adoption of digital technologies, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Wolter Kluwer, Philips Healthcare, Elsevier, McKesson, and Oracle.
Netherlands Oncology Clinical Trials Market Analysis
Netherlands oncology clinical trials Market is projected to grow from $32.9 Mn in 2022 to $52.4 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the country's strong healthcare system, experienced clinical researchers, and a supportive government. The market is segmented by phase, by study design & by indication. Some of the major players include Roche Holding AG, Pfizer Inc & Kiadis Pharma.
Netherlands Neurology Clinical Trials Market Analysis
Netherlands's Neurology Clinical Trials market is projected to grow from $13.6 Mn in 2022 to $21.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the modern healthcare infrastructure and an innovative & collaborative research environment. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen Netherlands BV, Roche Holding AG & Johnson & Johnson.
Netherlands Digital Health Market Analysis
Netherlands's Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the high-quality healthcare services of The Netherlands and the adoption of digitization by the population. The market is segmented by solution, by deployment & by end-use. Some of the major players include Royal Philips, Medtronic & Qompium.
Netherlands Diabetes Therapeutics Market Analysis
Netherlands's diabetes therapeutics market is expected to witness growth from $374 Mn in 2022 to $814 Mn in 2030 with a CAGR of 10.2% for the forecasted year 2022-30. The rising aging population of the country and the introduction of novel therapeutic options for diabetes in the Netherlands are driving the growth of the market. The Netherlands diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Produlab Pharma, Drogisterij-Parfumerie Visser, and Boehringer Ingelheim are the major players in the Netherlands diabetes therapeutics market.
Netherlands Diabetes Drugs Market Analysis
This report presents a strategic analysis of the Netherlands Diabetes Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Netherlands Diabetes Drugs Market, offering unmatched value, accuracy, and expert insights.
Netherlands Coronary Stents Market Analysis
Netherlands's Coronary Stents Market is expected to witness growth from $29 Mn in 2022 to $44 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. The elderly in the Netherlands are becoming more prevalent, which increases their chance of developing coronary artery disease. The demand for coronary stents and other cardiovascular devices is anticipated to rise as the population continues to age. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Hy2Care B.V., InnoSer, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
Netherlands Contraceptive Devices Market Analysis
Netherlands's Contraceptive Devices Market is expected to witness growth from $34 Mn in 2022 to $64 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. In the Netherlands, as consumers become more aware of the benefits of family planning and contraception, there is an increase in the demand for contraceptive devices. The market is segmented by type and by gender. Some key players in this market include Hy2Care B.V., InnoSer, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Netherlands Cancer Immunotherapy Market Analysis
Netherlands's cancer immunotherapy market is expected to witness growth from $293 Mn in 2022 to $526 Mn in 2030 with a CAGR of 7.6% for the forecasted year 2022-30. The increased funding in research and development and the creation of novel immunotherapy options are driving the growth of the market. The Netherlands cancer immunotherapy market is segmented by type, application, and end user. Bedrocan, Pharma Line, and Bayer are the major players in the Netherlands' cancer immunotherapy market.
Netherlands Bioinformatics Market Analysis
Netherlands's Bioinformatics market is projected to grow from $39.91 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be strong research and development capabilities, a high level of collaborations and partnerships, and government support. The market is segmented by technology and by application. Some of the major players include Microbial Bioinformatics (NLD), Enpicom (NLD), Crown Bioscience, Illumina, Agilent Technologies, IBM Life Sciences, and Qiagen.
Netherlands ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Netherlands ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Netherlands ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy, and expert insights.
Netherlands Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Netherlands Oncology Therapeutics Market will reach a value of $934 Mn from $472 Mn in 2022, growing at a CAGR of 8.9% during 2022-30. The Oncology Therapeutics Market in the Netherlands is dominated by a few domestic pharmaceutical companies such as Kiadis Pharma, AM-Pharma, and Vico Therapeutics. The Oncology Therapeutics Market in the Netherlands is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Netherlands Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Netherlands Depression Therapeutics Market Analysis
Netherlands' depression therapeutics market is expected to grow from $26 Mn in 2022 to $41 Mn in 2030 with a CAGR of 5.7% for the forecasted year 2022-30. Supportive government policies in the Netherlands related to depression and mental health as well as new and innovative technological advancements in the treatment of depression have led to the development of the market. The Netherlands' depression therapeutics market is segmented by drug type, therapies, indication, and end users. Xenikos, Dannalab, and Pfizer are the major players in the Netherlands' depression therapeutics market.
Netherlands 3D Imaging Market Analysis
Netherlands's 3D imaging market is projected to grow from $0.08 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by a solid healthcare infrastructure, a thriving research and development industry, and rising demand for new medical technology. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Pie Medical Imaging.
Netherlands Medical Devices Market Analysis
This report presents a strategic analysis of the Netherlands Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Netherlands Medical Devices Market, offering unmatched value, accuracy and expert insights.
Netherlands Home Healthcare Market Analysis
Netherlands's home healthcare market was valued at $943 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $1736 Mn in 2030. One of the main reasons propelling the growth of this market aging population and the rising prevalence of chronic disease. The market is segmented by equipment and service. Some key players in this market are Molnlycke Health Care, ConvaTec Group plc, Melsungen AG, Hollister, Coloplast, Medline Industries, and Acelity among others.
Netherlands Artificial Intelligence (AI) in Healthcare Market Analysis
Netherlands's Artificial Intelligence (AI) In healthcare market is projected to grow from $0.02 Bn in 2022 to $0.36 Bn by 2030, registering a CAGR of 45.72% during the forecast period of 2022 - 2030. The market will be driven by the country’s strong healthcare system, a culture of innovation and collaboration, and government assistance for research and development. The market is segmented by healthcare components & by healthcare applications. Some of the major players include Philips Healthcare, Aidence & Quantib.
Netherlands Dental Care Market Analysis
The Dental care services market size is at around $93.29 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. The provision of advanced dental care like orthodontics, periodontal surgeries, and prosthodontic rehabilitation are the major trends and captured by key players like Tandartspraktijk Klaver, Tandartspraktijk Praktijk Noord, Tandartspraktijk Middenmeer who are based locally. This report by Insights10 is segmented by treatment type, age group, and clinical setup, and by demography.
Netherlands Cardiovascular Diseases Therapeutics Market Analysis
The Netherlands cardiovascular disease therapeutics market is expected to witness growth from $423 Mn in 2022 to $767 Mn in 2030 with a CAGR of 7.72% for the year 2022-2030. The Netherlands being the hub for rising trends in biochemistry, genetics, and molecular biology and the increase in demand for advanced therapeutics for the treatment of cardiovascular diseases in the Netherlands are the major factors responsible for the expansion of the market. The Netherlands cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Northsea Therapeutics, Dannalab, and AstraZeneca are the major players in the Netherlands cardiovascular disease therapeutics market.
Netherlands Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Netherlands Lung Cancer Therapeutics Market will reach a value of $155 Mn from $77 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in the Netherlands is dominated by a few domestic pharmaceutical companies such as Cristal Therapeutics, ISA Pharmaceuticals, and Merus. The Lung Cancer Therapeutics Market in the Netherlands is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Netherlands lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Netherlands Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Netherlands liver disease therapeutics market will reach a value of $97 Mn from $60 Mn in 2022, growing at a CAGR of 6.2 % during 2022-2030. Liver disease therapeutics in the Netherlands is dominated by a few domestic pharmaceutical companies such as Astellas Pharma, Philips Healthcare, and Pharming Group. The liver disease therapeutics market in the Netherlands is segmented into different types of disease and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.